Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Belgium
Clinical trial register · European Union · CTIS

Clinical Trials in Belgium, 2026

The most recently authorised trials on the EU Clinical Trials Information System (CTIS), the single register for every trial run under the EU Clinical Trials Regulation (536/2014). CTIS holds a far larger historical archive than any one list can usefully show — this register states both numbers rather than picking one.

Download CSV
Source: EMA Clinical Trials Information System (CTIS). Showing the 2556 most recently authorised of 12766 total CTIS records — a stated recency window, not the full historical archive. Synced 04 Nov 2026, 03:17 UTC
2556
Shown in this register
most recently authorised
12,766
Total on CTIS
full historical archive
788
Phase III
within the shown window
Top member states
Spain 1071 France 936 Germany 897 Italy 779 Poland 622 Netherlands 547
Narrow the registerReset
Phase
Phase I 562 Phase I/II 228 Phase II 725 Phase III 788 Phase IV 253
Lead sponsor
AstraZeneca AB 65 Merck Sharp & Dohme LLC 50 Assistance Publique Hopitaux De Paris 50 Pfizer Inc. 49 Novartis Pharma AG 47 Clear sponsor filter
Member state
Spain 1071 France 936 Germany 897 Italy 779 Poland 622 Netherlands 547 Belgium 456 Czechia 338
All 28 states

Trials with a site in Belgium

0 of 2556 shown studies
Download
Phase
Study
Lead sponsor
Area
Member states
Decision
No studies match these filters
Widen the phase or country selection, or clear the search term.
Rows per page Showing 0–0 of 0
1
Cite this view

Priya Life Science (2026). EU Clinical Trials Register (CTIS), filtered. Derived from the EMA Clinical Trials Information System. Retrieved 4 November 2026. https://priyalifescience.com/clinical-trials-europe/country/belgium

Query this register directly
GET /api/export.php?register=trials-eu&format=json Try it now →

About this register

This register is built from the EU Clinical Trials Information System (CTIS), run by the European Medicines Agency: the single register for every trial authorised under the EU Clinical Trials Regulation (536/2014). CTIS held 12,766 trial records at the last sync on 04 Nov 2026, 03:17 UTC; this register shows the 2,556 most recently authorised of them, a stated recency window rather than the full archive. The list can be downloaded as CSV or JSON.

This page shows the 0 of those trials with a site in Belgium that also match the filters currently applied.

How many recently authorised EU trials have a site in Belgium?

0 of the 2,556 most recently authorised trials in this register list a site in Belgium and match the filters applied; 0 of them are Phase III. Trials are counted by authorisation on CTIS, not by recruitment status, which CTIS does not publish in the same form as ClinicalTrials.gov.

Listing here is informational and not medical advice; eligibility is determined by each study team. Looking for Irish sites? See the Ireland, UK or USA registers. For approved medicines, see the EMA Approvals Tracker.